Back to Iris Pharma home page

Home  |  Contact  |  Sitemap    |  Restricted area  

Phase IV

Iris Pharma is a leading, therapeutically specialized Contract Research Organization (CRO) focused on ophthalmology clinical trials.


We offer partial or full-service phase IV medical writing, clinical trial monitoring and project management depending on client specific requirements. Our priority is to give a reliable solution to all situations.

 

Our clinical trial services bring together an extensive network of professionals with experience in undertaking Phase IV clinical trials in ophthalmology in France, Austria, Belgium, Denmark, Eastern Europe (Bulgaria, Czech Republic, Poland, Romania), Eire, Germany, India, Israel, Italy, Morocco, North America (USA and Canada), Portugal, Saudi Arabia, Spain, Switzerland, The Netherlands, Tunisia, Turkey and the United Kingdom.

Add to favoritesPrintSend to a friend

Related links

Fields of expertise

• Glaucoma/Ocular hypertension
• Dry eye syndrome, Gougerot-Sjögren syndrome
• Retinal disorders (Age-related Macular Degeneration (AMD or ARMD))
• Diabetic retinopathy
• Eye socket disorders (infection, inflammation)
• Ocular allergy
• Cataract surgery (LASIK PRK)
• Conjunctival disorders (allergic conjunctivitis, keratoconjunctivitis Sicca, trachoma)
• Orphan disease
• Medical devices
• Contactology
• Post surgical inflammation
• Ocular rosacea

» Back to the top

IRIS Pharma